Ambroxol is a mucolytic agent belonging to the class of benzylamine derivatives, widely indicated as a secretolytic therapy for bronchopulmonary diseases characterized by abnormal mucus secretion and impaired… Read more







![Chemical structure of 4-[[(2-Amino-3,5-dibromophenyl)methylene]amino]cyclohexanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1445719-53-8-4-2-Amino-35-dibromophenylmethyleneaminocyclohexanol.png&w=3840&q=75)











![Chemical structure of cis-4-[[(2-Amino-3,5-dibromophenyl)methylene]amino]cyclohexanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2499966-00-4-cis-4-2-Amino-35-dibromophenylmethyleneaminocyclohexanol.png&w=3840&q=75)
![Chemical structure of cis-[2-(4-tert-Butyloxycarbonylamino)cyclohexyloxy]tetrahydro-2H-pyran-d5](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1322626-64-1-cis-2-4-tert-Butyloxycarbonylaminocyclohexyloxytetrahydro-2H-pyran-d5.png&w=3840&q=75)







![Chemical structure of Trans-4-[[(2-Aminophenyl)methyl]amino]cyclohexanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F46727-91-7-Trans-4-2-Aminophenylmethylaminocyclohexanol.png&w=3840&q=75)
![Chemical structure of trans-[2-(4-tert-Butyloxycarbonylamino)cyclohexyloxy]tetrahydro-2H-pyran-d5](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1322626-69-6-trans-2-4-tert-Butyloxycarbonylaminocyclohexyloxytetrahydro-2H-pyran-d5.png&w=3840&q=75)
Ambroxol is a mucolytic agent belonging to the class of benzylamine derivatives, widely indicated as a secretolytic therapy for bronchopulmonary diseases characterized by abnormal mucus secretion and impaired mucus transport. This category provides an extensive collection of reference standards for the active pharmaceutical ingredient, alongside a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, metabolites such as O-glucuronide, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories engaged in rigorous impurity profiling, method validation, and routine quality control. By utilizing these characterized substances, analysts can effectively identify and quantify degradation products, process-related impurities, and synthetic intermediates to ensure consistent regulatory compliance. This portfolio includes diverse structural analogs, such as benzoic acid and cycloimine derivatives, offering the precise analytical tools necessary to maintain product integrity and safety during the development and manufacturing lifecycle of respiratory therapeutic products.